OBRIEN MORGAN E 4

4 · Anterix Inc. · Filed Mar 15, 2023

Form 4

Period: 2023-03-13

DirectorVice Chairman of the Board

Transactions

Exercise/Conversion
Common Stock
2023-03-13$20.00/sh+20,000$400,000→ 51,947 total
Exercise/Conversion
Common Stock
2023-03-13$22.75/sh+20,000$455,000→ 71,947 total
Sale
Common Stock
2023-03-13$30.29/sh−5,000$151,473→ 66,947 total
Sale
Common Stock
2023-03-13$30.01/sh−40,000$1,200,500→ 26,947 total
Gift
Common Stock
2022-10-12−1,000→ 25,947 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-03-13−20,000→ 0 total
Exercise: $20.00Exp: 2024-05-14→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-03-13−20,000→ 34,945 total
Exercise: $22.75Exp: 2027-05-22→ Common Stock (20,000 underlying)

Footnotes (4)

[F1]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.79 to $30.56. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F2]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.77 to $30.28. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F3]These transactions represent a charitable contribution by the Reporting Person.
[F4]The option shares are fully vested.

Documents

1 file